• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Design Therapeutics Inc (NQ: DSGN )

    4.040 -0.420 (-9.42%)
    Streaming Delayed Price Updated: 2:50 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Design Therapeutics Inc

    < Previous 1 2 3 Next >
    The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
    Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them. 
    Via InvestorPlace
    DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024
    DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023
    DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Earnings Preview For Design Therapeutics
    Via Benzinga
    Earnings Scheduled For March 19, 2024
    Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
    All three leading U.S. stock indices — the S&P 500, Nasdaq 100, and Russell 2000 — have simultaneously breached a crucial technical support level this week. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
    RBC Capital Market downgraded Design Therapeutics Inc (NASDAQ: DSGN) from Outperform to Sector Perform with a price target of $7,  
    Via Benzinga
    Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Shares of Design Therapeutics Are Plummeting on Tuesday
    The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy. 
    Via The Motley Fool
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 90 points on Tuesday. The Dow traded down 0.75% to 35,042.16 while the NASDAQ fell 0.66% to 13,697.15. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
    Via Benzinga
    Dow Falls Over 200 Points; US Retail Sales Top Expectations
    U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.67% to 35,069.60 while the NASDAQ fell... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Is Design Therapeutics Stock Moving Lower Today?
    Design Therapeutics Inc (NASDAQ: DSGN) reported initial results from the company's Phase 1 multiple-ascending dose (MAD) clinical trial of DT-216 in  
    Via Benzinga
    Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
    Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with... 
    Via Benzinga
    Exposures Product Safety
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday! 
    Via InvestorPlace
    Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
    Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of  
    Via Benzinga
    Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
    Via Benzinga
    Why Design Therapeutics (DSGN) Stock Is Going Nowhere But Down
    Design Therapeutics has multiple research programs and a strong drive to combat genetic disorders, but that's not enough to save DSGN stock. 
    Via InvestorPlace
    Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze
    Short squeeze stocks are all over Wall Street in the wake of the regional banking crisis. Which names should you keep an eye out for? 
    Via InvestorPlace
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.